Beckman Coulter launched the new DxI 9000 Immunoassay Analyzer

Door: ANALIS sa nv

Reimagine what’s possible with the new DxI 9000 Immunoassay Analyzer to enhance precision and create time for you to focus what matters most.

A new generation immunoassay analyzer: the BECKMAN COULTER DxI 9000

  • ZeroDaily maintenance
  • Save time
  • Improve Precision
  • Operator tutorial guidance: user-friendly & Intuitive navigation
  • Empower lab productivity
  • The DxI 9000 analyzer has been designed to meet current laboratory expectations in terms of productivity, robustness and quality of results. Users will appreciate the analyzer's throughput (450 tests/h), the absence of daily maintenance (ZeroDaily maintenance), but also the PrecisionVision technology which guarantees the security of the analytical process for each sample and the SimpleSolve Onboard Guide which optimizes system availability. »

The DxI 9000 analyzer has also obtained FDA approval and is CE marked according to the IVDR 2017/746 regulation. In evaluations by independent laboratories, it also showed excellent accuracy against EFLM (European Federation of Clinical Chemistry and Laboratory Medicine) criteria. »

→ ZeroDaily maintenance which eliminates daily loss of operator time and risk of instrument downtime. Beta users attest that ZeroDaily maintenance eliminates daily maintenance requirements from their workday, reducing annual maintenance routines by up to 96%.

→ PrecisionVision technology to control the process, builds on Beckman Coulter's leadership in workflow and automation. PrecisionVision's built-in and automated safety features include tube identification, cap detection, disposable pipetting tip presence check, control of sample volumes aspirated and dispensed, residual wash volumes and volumes of substrate dispensed into the reaction vessel. Each check reduces the risk of erroneous data and increases the reliability and reproducibility of the system.

→ The SimpleSolve Onboard Guide is an automated, intuitive and interactive tutorial, developed by Beckman Coulter to guide users step by step so that they can independently identify the causes of incidents and resolve them. Operators gain peace of mind and the analyzer is available more quickly. Another key system innovation is the new Lumi-Phos PRO substrate for increasingly sensitive and clinically relevant assays, ensuring the DxI 9000's ability to meet tomorrow's healthcare needs.»

Explore more 

https://analis.be/en-us/immunoassay/   

https://www.beckmancoulter.com/en/products/immunoassay/dxi-9000-access-immunoassay-analyzer

Contact our expert Ronald Bailly  RBY@ANALIS.BE

 

 

View all exhibitor news